Hamava managers believe that soon we will be able to see that Vpon and Biolab teams will take over a large part of the respective market.
According to Iran digital economy annotation, Hamava investor and accelerator company has recently invested in two startups, Biolab and Vpon. These two startups were selected from among 40 applicant startups and have been successful in attracting capital by the Hamava investment committee.
Biolab company works to meet laboratory and research needs in order to facilitate services to prestigious research and academic centers, students and other groups. Biolab company also works in meeting laboratory and research needs in order to facilitate services to prestigious research and academic centers of students and other classes. Vpon startup also provides electrical and electrical online services to Iranian companies and households.
“Soheil Abbasi”, the vice president of entrepreneurship and innovation of Hamava, considered the purpose of Hamava’s investment in these two startups to match their innovative system with Hamava. With the aim of investing and accelerating technological startups, among 40 applicant startups, two startups, Biolab and Vpon, were selected as a result of the startup screening and review process by Hamava’s investment committee.”
Abbasi considered the investment in startup Biolab to have features such as having a solution based on innovation and technology and stated: “Biolab’s cohesive team has complementary skills and has a favorable experience in the relevant industry. Also, their proper understanding of the problem and having solutions based on innovation and technology were significant features for us. “The Biolab team knows the stakeholders and has competitive advantages.”
Vpon startup also provides online electrical services to Iranian companies and households. Emphasizing the high competitive advantage of this team, Vice President of Entrepreneurship and Innovation Hamava believes that Vpon offers the right product by identifying its stakeholders in the market, and with a long experience in the relevant industry, it has been able to provide validated solutions.
Hamaava’s vice president of entrepreneurship and innovation said: “The amount of Hamava’s investment in these startups in the form of pre-seed investment, 750 million tomans (approximately 15,000$) each in cash and non-cash for shares, was very minimal.”
The vice president of entrepreneurship and innovation at Hamava explained about the company’s future plans: “In the Hamaava acceleration program, we will try to help startups, based on designed processes, to improve and develop their initial product with less time and financial cost, traction Measure the market, test better, faster and more efficient channels to enter the market, identify the optimal way of communication and improve customer communication processes. Also, connect them to related business networks and investors, and finally raise the level of investment readiness of their business to attract capital for further growth and development stages.”
At the end, Abbasi added: “According to the negotiations and interactions that have taken place with the big players of this industry, we can soon see that Vpon and Biolab teams will take over a large part of the relevant market.”
No Comment! Be the first one.